In Wake Of Medivation Deal, Argus Thinks Pfizer's Existing Business Is Underrated
August 29, 2016 at 11:21 AM EDT
On August 22, Pfizer Inc. (NYSE: PFE) announced it had entered into an agreement to acquire Medivation Inc (NASDAQ: MDVN) for almost $14 ...
